IL-24 and IL-22R were reduced and correlated inversely to the elevated levels of lymphangiogenic markers, suggesting that the lack of IL-24 could enhance lymphangiogenesis, tumor growth, and dissemination in breast cancer. This evidence concerns the gene IL22RA1 and breast carcinoma.